This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Androgen transition and management of hereditary angioedema long‑term prophylaxis in real life: a single‑center case series

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Managing Diagnosis, Treatment and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Optimal Management of Hereditary Angioedema: Shared Decision-Making

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Meeting Patient Needs in Hereditary Angioedema Care

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Once-daily oral berotralstat for long-term prophylaxis of hereditary angioedema: The open-label extension of the APeX-2 randomized trial

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
Previous Page
1 2 3 4 … 9
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional